Variation in the FFAR1 gene modifies BMI, body composition and beta-cell function in overweight subjects: an exploratory analysis

Background FFAR1 receptor is a long chain fatty acid G-protein coupled receptor which is expressed widely, but found in high density in the pancreas and central nervous system. It has been suggested that FFAR1 may play a role in insulin sensitivity, lipotoxicity and is associated with type 2 diabete...

Full description

Bibliographic Details
Main Authors: Walker, C, Goff, L, Bluck, L, Griffin, B, Jebb, SA, Lovegrove, J, Sanders, T, Frost, G
Format: Journal article
Language:English
Published: Public Library of Science 2011
_version_ 1797061691482046464
author Walker, C
Goff, L
Bluck, L
Griffin, B
Jebb, SA
Lovegrove, J
Sanders, T
Frost, G
author_facet Walker, C
Goff, L
Bluck, L
Griffin, B
Jebb, SA
Lovegrove, J
Sanders, T
Frost, G
author_sort Walker, C
collection OXFORD
description Background FFAR1 receptor is a long chain fatty acid G-protein coupled receptor which is expressed widely, but found in high density in the pancreas and central nervous system. It has been suggested that FFAR1 may play a role in insulin sensitivity, lipotoxicity and is associated with type 2 diabetes. Here we investigate the effect of three common SNPs of FFAR1 (rs2301151; rs16970264; rs1573611) on pancreatic function, BMI, body composition and plasma lipids. Methodology/Principal Findings For this enquiry we used the baseline RISCK data, which provides a cohort of overweight subjects at increased cardiometabolic risk with detailed phenotyping. The key findings were SNPs of the FFAR1 gene region were associated with differences in body composition and lipids, and the effects of the 3 SNPs combined were cumulative on BMI, body composition and total cholesterol. The effects on BMI and body fat were predominantly mediated by rs1573611 (1.06 kg/m2 higher (P = 0.009) BMI and 1.53% higher (P = 0.002) body fat per C allele). Differences in plasma lipids were also associated with the BMI-increasing allele of rs2301151 including higher total cholesterol (0.2 mmol/L per G allele, P = 0.01) and with the variant A allele of rs16970264 associated with lower total (0.3 mmol/L, P = 0.02) and LDL (0.2 mmol/L, P<0.05) cholesterol, but also with lower HDL-cholesterol (0.09 mmol/L, P<0.05) although the difference was not apparent when controlling for multiple testing. There were no statistically significant effects of the three SNPs on insulin sensitivity or beta cell function. However accumulated risk allele showed a lower beta cell function on increasing plasma fatty acids with a carbon chain greater than six. Conclusions/Significance Differences in body composition and lipids associated with common SNPs in the FFAR1 gene were apparently not mediated by changes in insulin sensitivity or beta-cell function.
first_indexed 2024-03-06T20:34:52Z
format Journal article
id oxford-uuid:324ac4a4-60a2-4ab7-9e15-6e0febea65b9
institution University of Oxford
language English
last_indexed 2024-03-06T20:34:52Z
publishDate 2011
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:324ac4a4-60a2-4ab7-9e15-6e0febea65b92022-03-26T13:13:05ZVariation in the FFAR1 gene modifies BMI, body composition and beta-cell function in overweight subjects: an exploratory analysisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:324ac4a4-60a2-4ab7-9e15-6e0febea65b9EnglishSymplectic Elements at OxfordPublic Library of Science2011Walker, CGoff, LBluck, LGriffin, BJebb, SALovegrove, JSanders, TFrost, GBackground FFAR1 receptor is a long chain fatty acid G-protein coupled receptor which is expressed widely, but found in high density in the pancreas and central nervous system. It has been suggested that FFAR1 may play a role in insulin sensitivity, lipotoxicity and is associated with type 2 diabetes. Here we investigate the effect of three common SNPs of FFAR1 (rs2301151; rs16970264; rs1573611) on pancreatic function, BMI, body composition and plasma lipids. Methodology/Principal Findings For this enquiry we used the baseline RISCK data, which provides a cohort of overweight subjects at increased cardiometabolic risk with detailed phenotyping. The key findings were SNPs of the FFAR1 gene region were associated with differences in body composition and lipids, and the effects of the 3 SNPs combined were cumulative on BMI, body composition and total cholesterol. The effects on BMI and body fat were predominantly mediated by rs1573611 (1.06 kg/m2 higher (P = 0.009) BMI and 1.53% higher (P = 0.002) body fat per C allele). Differences in plasma lipids were also associated with the BMI-increasing allele of rs2301151 including higher total cholesterol (0.2 mmol/L per G allele, P = 0.01) and with the variant A allele of rs16970264 associated with lower total (0.3 mmol/L, P = 0.02) and LDL (0.2 mmol/L, P<0.05) cholesterol, but also with lower HDL-cholesterol (0.09 mmol/L, P<0.05) although the difference was not apparent when controlling for multiple testing. There were no statistically significant effects of the three SNPs on insulin sensitivity or beta cell function. However accumulated risk allele showed a lower beta cell function on increasing plasma fatty acids with a carbon chain greater than six. Conclusions/Significance Differences in body composition and lipids associated with common SNPs in the FFAR1 gene were apparently not mediated by changes in insulin sensitivity or beta-cell function.
spellingShingle Walker, C
Goff, L
Bluck, L
Griffin, B
Jebb, SA
Lovegrove, J
Sanders, T
Frost, G
Variation in the FFAR1 gene modifies BMI, body composition and beta-cell function in overweight subjects: an exploratory analysis
title Variation in the FFAR1 gene modifies BMI, body composition and beta-cell function in overweight subjects: an exploratory analysis
title_full Variation in the FFAR1 gene modifies BMI, body composition and beta-cell function in overweight subjects: an exploratory analysis
title_fullStr Variation in the FFAR1 gene modifies BMI, body composition and beta-cell function in overweight subjects: an exploratory analysis
title_full_unstemmed Variation in the FFAR1 gene modifies BMI, body composition and beta-cell function in overweight subjects: an exploratory analysis
title_short Variation in the FFAR1 gene modifies BMI, body composition and beta-cell function in overweight subjects: an exploratory analysis
title_sort variation in the ffar1 gene modifies bmi body composition and beta cell function in overweight subjects an exploratory analysis
work_keys_str_mv AT walkerc variationintheffar1genemodifiesbmibodycompositionandbetacellfunctioninoverweightsubjectsanexploratoryanalysis
AT goffl variationintheffar1genemodifiesbmibodycompositionandbetacellfunctioninoverweightsubjectsanexploratoryanalysis
AT bluckl variationintheffar1genemodifiesbmibodycompositionandbetacellfunctioninoverweightsubjectsanexploratoryanalysis
AT griffinb variationintheffar1genemodifiesbmibodycompositionandbetacellfunctioninoverweightsubjectsanexploratoryanalysis
AT jebbsa variationintheffar1genemodifiesbmibodycompositionandbetacellfunctioninoverweightsubjectsanexploratoryanalysis
AT lovegrovej variationintheffar1genemodifiesbmibodycompositionandbetacellfunctioninoverweightsubjectsanexploratoryanalysis
AT sanderst variationintheffar1genemodifiesbmibodycompositionandbetacellfunctioninoverweightsubjectsanexploratoryanalysis
AT frostg variationintheffar1genemodifiesbmibodycompositionandbetacellfunctioninoverweightsubjectsanexploratoryanalysis